Hyperglycemia associated with protease inhibitors in HIV-1-infected patients.
Gómez-Vera
J
J
Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, c/Manuel Siurot s/n, 41013 Seville, Spain. aristide@cica.es
de Alarcón
A
A
Jiménez-Mejías
M E
ME
Acosta
D
D
Prados
D
D
Viciana
P
P
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002096:C-Peptide / Q000378:metabolism; D003920:Diabetes Mellitus / Q000139:chemically induced*; D006442:Glycated Hemoglobin; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D008297:Male; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D000998:Antiviral Agents; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin; D011480:Protease Inhibitors